Co-Founder & CEO

Co-founder & SVP of Business Operations

GenEdit Appoints Dr. J. Rodrigo Mora as Chief Scientific Officer to Expand Its NanoGalaxy® Genetic Medicine Platform into Immunology

GenEdit aims to expand with gene therapy - Pulse by Maeil Business News Korea

GenEdit Announces Multiyear Collaboration and License Agreement with Genentech to Develop Novel Nanoparticles ...

Delivery Is One of the Biggest Challenges for Genetic Medicine. A New Collaboration Aims to Help Resolve It.

Sr. Consultant, mRNA Engineering

GenEdit is a rapidly growing, early-stage company developing a proprietary delivery platform to transform genetic medicine. They are seeking a Sr. Consultant with expertise in mRNA engineering to assist cross-functional teams in the creation of novel drug candidates.

Sign up with Google

Sign in with Google